Our team is passionate about studying mechanisms of tumor progression, metastases and drug resistance in hormone receptor positive breast cancer.
We employ high throughput assays to study genomics, epigentics, the tumor micro-environment and single cell analyses in cell lines, patient derived xenografts and clinical samples.
Our mission is to develop novel therapeutic strategies to be translated to the clinic and improve outcomes in breast cancer patients.